I am a diagnostic radiologist and nuclear medicine physician with specialty training in oncologic and molecular imaging. My overriding goal is to create comprehensive and clinically relevant interpretations of imaging studies through the integration of anatomic, morphologic, and functional information. Additionally, I use my broad clinical experience and expertise to treat patients with cancer using targeted radionuclide therapy.
I am an active member of Memorial Sloan Kettering’s multidisciplinary Hepatobiliary and Pancreatic Tumors Disease Management Team and provide guidance for treatment decisions. I am involved in various research studies designed to improve the diagnosis and treatment for people with cancer and am particularly interested in the development of novel molecular imaging modalities such as PET/CT to ensure the highest standard of care for each patient.
- Clinical Expertise: Diagnostic Radiology; Nuclear Medicine; Molecular Imaging and Targeted Radionuclide Therapy
- Languages Spoken: English; German
- Education: MD, Albert Ludwigs University of Freiburg (Germany)
- Residencies: Albert Ludwigs University of Freiburg (Germany)
- Fellowships: Memorial Sloan Kettering Cancer Center
As home to one of the world’s top cancer research centers, Memorial Sloan Kettering is typically involved in more than 900 clinical trials at a given time. Currently, clinical trials focused on the conditions I treat are enrolling new patients. If you’re interested in joining a clinical trial, click to learn about the trial’s purpose, eligibility criteria, and how to get more information.Learn more
Most major health insurers offer plans that include MSK as one of their in-network providers. If MSK is in-network, it means all our doctors are too. Medicaid and New York State Medicare also provide benefits for care at MSK.Learn more